ArticleBrain and behavior2017

Gender differences in safety issues during Fingolimod therapy: Evidence from a real-life Relapsing Multiple Sclerosis cohort.

Alessia Manni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.